Rybelsus bioavailability changes

There is a lot of concern regarding the potential for errors. Community pharmacy will be integral to ensuring that patients are informed of and supported with these changes.

Please find the detailed information below:

DHPC Letter- Rybelsus (oral semaglutide): risk of medication error due to introduction of new formulation with increased bioavailability

Document